decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / SENSORY_NERVE_CONDUCTION_THRESHOLD_TEST1
Subscribe or sign in to view the full article.
Article Overview
This Medicare coverage article explains the National Coverage Determination for sensory nerve conduction threshold testing (sNCT). It is relevant to clinicians, coders, and compliance staff who need to understand how CMS characterizes the test, how it differs from other nerve-conduction and evoked-potential studies, and the coverage status associated with diagnostic uses discussed in the policy.
Why This Topic Matters
Coverage determinations affect whether services are considered reimbursable under Medicare and help coders and compliance teams avoid using the wrong procedure category for this test. The article also clarifies the policy context for related sensory testing approaches and the versioning history of the NCD.
Article Sections
-
General
Provides an overview of sensory nerve conduction threshold testing, its purpose, and how it is distinguished from other nerve and evoked-potential assessments. Also summarizes the CMS policy history and the general coverage status discussed in the determination.
-
Nationally Covered Indications
States the covered-indication status for the procedure under this Medicare policy.
-
Nationally Noncovered Indications
Summarizes the noncovered-use category addressed in the determination and notes the review status of the policy.
What You Will Learn
- What sensory nerve conduction threshold testing is intended to assess
- How sNCT is distinguished from other nerve-function studies
- What the Medicare coverage article says about covered and noncovered uses
- How the policy is positioned within the National Coverage Determinations Manual
Who Should Read This
- Medical coders
- Compliance professionals
- Billing staff
- Neurology practices
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com